Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment

American Journal of Infection Control

Volumn 44, Issue 2, 2016, Pages 134-137

  Miller, Brooke M ^a   Johnson, Steven W ^a,b  

^a FORSYTH MEDICAL CENTER   (United States)

^b CAMPBELL UNIVERSITY   (United States)

Author keywords

Carbapenem resistant Enterobacteriaceae; CRE; Enterobacteriaceae; Prediction model; Risk factors

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM; QUINOLONE DERIVATIVE; CARBAPENEM DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE CONTROL STUDY; CHARLSON COMORBIDITY INDEX; COMMUNITY HOSPITAL; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; ENTEROBACTERIACEAE INFECTION; FEMALE; HOSPITAL PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ADOLESCENT; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; VERY ELDERLY;

ADOLESCENT; AGED; AGED, 80 AND OVER; BETA-LACTAM RESISTANCE; CARBAPENEMS; CASE-CONTROL STUDIES; DEMOGRAPHY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALIZATION; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84958832319     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.09.006     Document Type: Conference Paper

References (15)

1. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/. Accessed August 11, 2014.
2. E.T. Martin, R. Tansek, V. Collins, K. Hayakawa, O. Abreu-Lanfranco, T. Chopra, and et al. The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients Am J Infect Control 41 2013 180 182
3. M.J. Schwaber, S. Klarfeld-lidji, S. Navon-venezia, D. Schwartz, A. Leavitt, and Y. Carmeli Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality Antimicrob Agents Chemother 52 2008 1028 1033
4. G.C. Lee, K.A. Lawson, and D.S. Burgess Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study Ann Pharmacother 47 2013 1115 1121
5. th informational supplement 2009 CLSI Wayne [PA] CLSI document M100-S19
6. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
7. S.W. Johnson, D.J. Anderson, D.B. May, and R.H. Drew Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission Infect Control Hosp Epidemiol 34 2013 385 392
8. J.P. Furuno, A.D. Harris, M.O. Wright, J.C. McGregor, R.A. Venezia, J. Zhu, and et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission Am J Infect Control 32 2004 436 440
9. M. Tumbarello, E.M. Trecarichi, M. Bassetti, F.G. De Rosa, T. Spanu, E. Di Meco, and et al. Identifying patients harboring extended-spectrum-β-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system Antimicrob Agents Chemother 55 2011 3485 3490
10. N. Gupta, B.M. Limbago, J.B. Patel, and A.J. Kallen Carbapenem-resistant enterobacteriaceae: epidemiology and prevention Clin Infect Dis 53 2011 60 67
11. E. Tacconelli, A.W. Karchmer, D. Yokoe, and E.M. D'Agata Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule Clin Infect Dis 39 2004 964 970
12. E. Tacconelli, M.A. Cataldo, A.G. De, and R. Cauda Risk scoring and bloodstream infections Int J Antimicrob Agents 30 Suppl 1 2007 S88 S92
13. S. Harbarth, H. Sax, C. Fankhauser-Rodriguez, J. Schrenzel, A. Agostinho, and D. Pittet Evaluating the probability of previously unknown carriage of MRSA at hospital admission Am J Med 119 2006 275.e15 275.e23
14. G.J. Van, E. Florence, and J. Van den Ende Validation of clinical scores for risk assessment Clin Infect Dis 54 2012 1520 1521
15. M.H. Zweig, and G. Campbell Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577